Log in
Donate

Clinical Trial: NRG GU009

NRG GU009

Status: Open

NCT#04513717

Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (PREDICT-RT*)

Eligible for screening study DCP 001

GU009, Intensification cohort (Groups 3 and 4) is closed to accrual effective 09/10/24 after 5:00 PM ET

Closure of Accrual for QOL Substudy for pateints enrolled in Arms 1 and 2, effective September 22, 2023

Optional Imaging Sub Study is temporarily closed accrual, effective December 21, 2021

View All Clinical Trials
The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer care to Montana, Idaho and Wyoming through National Cancer Institute (NCI) sponsored clinical research.

Navigation

About Us

Contact Us

Copyright © Montana Cancer Consortium | All rights reserved